ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1359 National Cancer Institute Html en Cancer Pain (PDQ®)–Health Professional Version Expert-reviewed information summary about pain as a complication of cancer or its treatment. Approaches to the management and treatment of cancer-associated pain are discussed.
initial pain assessment0.567168
baseline pain intensity0.558291
treats mild pain0.559952
moderate cancer pain0.617809
metastatic bone pain0.57198
incident cancer pain0.559612
acute pain resolves0.55829
pain management treatment0.568663
ongoing pain management0.552517
pain relief ladder0.55951
common cancer pain0.591113
Neuropathic Pain sections0.560808
somatic pain0.561569
indicates mild pain0.560721
cancer patients0.628525
pain intensity0.56637
pain management0.652391
neuropathic pain0.592568
Pain Symptom Manage0.699092
cancer pain control0.556765
Pain Management Nursing0.556277
Pain Physician0.561182
pain assessment0.597079
Pain Palliat Care0.567356
breakthrough cancer pain0.563775
visceral pain signals0.562249
severe cancer pain0.582593
PUBMED Abstract0.564761
visceral pain0.565502
pain assessment toolkit0.554382
mild pain0.57672
Effective pain management0.567467
cancer pain management0.592002
pain relief0.569023
moderate pain0.568137
cancer pain0.834476
American Pain Society0.557173
pain0.954306
acute pain0.572092
Abstract0.595673
Pain Med0.572479
Clin Oncol0.552396
severe pain0.584777
cancer pain experience0.579997
pain scale0.566028
pain levels0.565618
comprehensive pain assessment0.576005
indicates moderate pain0.564768
pain receptors0.555011
CLICK HERE
1415 National Cancer Institute Html en Grief, Bereavement, and Coping With Loss (PDQ®)–Patient Version Expert-reviewed report about grief, bereavement, and feelings of loss in survivors of someone who has died of cancer. Grief in children is also discussed.
normal grief process0.471417
Common grief reactions0.532686
grief pattern0.454756
bereaved person moves0.399208
family member0.390974
PDQ cancer information0.489866
unexpected loss0.387668
loss0.666269
children0.561087
typical grief response0.466341
PDQ Grief0.446846
clinical trials0.426876
grief0.931776
anticipatory grief0.60415
cancer information summary0.442789
social support0.46161
clinical trial0.441424
younger bereaved people0.426523
family members0.386464
Grief bursts0.441053
weight loss0.372081
bereaved people0.499808
severe grief0.457196
difficult grief0.440844
NCI PDQ cancer0.383634
grief reactions0.581886
person0.556278
grief symptoms0.442678
deceased person0.373691
child0.531789
distress0.378808
normal grief0.541883
death0.826955
Chronic grief0.43943
Cancer Information Service0.369255
complicated grief0.451713
National Cancer Institute0.448538
health care0.379094
grief process0.5341
Palliative Care Editorial0.392193
new treatment0.370063
different cultures0.372731
Care Editorial Board0.393341
people0.580964
way0.395094
grief treatment0.44457
comprehensive cancer information0.368169
depression0.378859
CLICK HERE
1735 National Cancer Institute Html en Reproductive History and Cancer Risk A fact sheet that describes what is known about the relationship between pregnancy, miscarriage, abortion, fertility treatment and the risk of cancer.
spontaneous abortion0.436313
additional full-term pregnancy0.438399
reproductive factors0.477411
British Journal0.464068
Breast Cancer Research0.554497
Long-term cancer risk0.463368
reduced risk0.446487
ovarian cancer0.487507
Smalley M. Pregnancy0.434754
future breast cancer0.499324
pregnancy0.509986
lower risk0.435353
cancer types0.43982
receptor-negative breast cancer0.516576
maternal breast cancer0.498304
slightly higher risk0.457714
Cancer Epidemiology0.469709
ovarian stimulation0.442204
breast cancer declines0.516281
endometrial cancer0.444521
International Journal0.437218
women0.502711
risk reduction0.435107
ovarian hormones0.434429
invasive ovarian cancer0.459634
breast cells0.485604
decreased risk0.446489
cancer cells0.451518
Breast cancer incidence0.495609
full-term pregnancy0.496243
Endocrine-Related Cancer0.440218
breast tissue0.475053
studies0.44347
epithelial ovarian cancer0.455081
ovarian cancer risk0.471705
epidemiological studies0.438401
higher risk0.46047
endocrine-related risk factors0.447705
breast cancer risk0.823683
receptor–positive breast cancer0.54092
breast cancer0.983763
van leeuwen fe0.44337
pregnancy-related factors0.45934
vitro fertilization0.434549
Colditz GA0.436762
fertility drugs0.477238
receptor–negative breast cancers0.493334
et al0.597414
Vatten LJ0.446247
CLICK HERE
1865 National Cancer Institute Html es Tratamiento de los síndromes mielodisplásicos (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento de los síndromes mielodisplásicos.
int-1-risk mds with0.306049
displasia multilinaje0.307414
results from0.303983
granulocyte colony-stimulating factor0.309016
neoplasias mieloides0.312984
Garcia-Manero G0.313072
único tratamiento0.304306
with erythropoietin0.312779
anomalía citogenética0.307792
fase ii0.312681
international prognostic scoring0.321295
anomalías citogenéticas0.312714
randomized study0.305169
risk factors0.304186
stem cell transplantation0.306118
displasia unilinaje0.30428
PDQ Fatiga0.308455
Hypoplastic myelodysplastic0.304869
syndromes treated with0.307198
MDS with0.310074
patients with0.448968
with granulocyte colony-stimulating0.305945
patients with lower0.307744
marrow transplantation0.304031
células madre0.305457
crecimiento mieloide0.304117
leucemia aguda0.308968
elderly patients with0.307457
síndromes mielodisplásicos0.421016
Anderson Cancer Center0.305709
hematopoietic stem-cell transplantation0.306245
syndrome results0.304563
SMD neutropénicos asintomáticos0.311641
PDQ Tratamiento0.30516
MD Anderson Cancer0.305795
PDQ Neoplasias0.304911
Clin Oncol0.347749
US patients with0.307961
Sekeres MA0.309258
Kantarjian H0.309886
Conditioning with targeted0.305451
Hellström-Lindberg E0.307604
prognostic scoring system0.330511
leucemia mieloide aguda0.3404
treated with0.308208
with recombinant0.304816
patients with myelodysplastic0.404348
from patients with0.307143
myelodysplastic syndrome0.965311
CLICK HERE
1870 National Cancer Institute Html es Tratamiento de los tumores de células germinativas del ovario (PDQ®)–Versión para profesionales de salud Resumen de información revisada por expertos acerca del tratamiento de los tumores de células germinativas del ovario.
germ-cell tumors0.421459
germ-cell tumors with0.411803
Obstet Gynecol0.406415
ovarian germ0.634072
malignant germ0.435096
endodermal sinus tumor0.403615
cell tumors treated0.404749
Liao SY0.410388
Adjuvant therapy0.410358
Gershenson DM0.467949
Current therapy0.403318
Williams SD0.494559
tumores malignos mixtos0.404882
Hacker NF0.402853
Instituto Nacional0.403668
high-dose chemotherapy0.403104
or etoposide0.404727
DiSaia PJ0.408704
Moore DH0.407371
University Medical Center0.403543
quimioterapia postoperatoria0.403765
Gynecol Oncol0.453558
pacientes jóvenes0.408368
lavados peritoneales0.410402
New York University0.403494
Icb Tumor0.403092
gynecologic oncology group0.703201
Blessing JA0.51199
Birch R0.404259
estadio iv0.424378
Einhorn LH0.40484
Dembo AJ0.402909
estadio ia0.408575
ovary with0.410468
Morris M0.407706
with advanced germ0.403782
IIIa Tumor0.403067
York University Medical0.403528
Intern Med0.411687
second-look laparotomy0.431921
Clin Oncol0.539728
estadio iii0.41476
cell tumors using0.405334
tumor macroscópico0.402814
Oncology Group Study0.403519
germ cell tumors0.985883
histerectomía abdominal0.412918
Cangir A0.408111
cell tumors with0.436879
CLICK HERE
3421 National Cancer Institute Html es Antioxidantes y prevención del cáncer Antioxidants are substances that may protect cells from the damage caused by unstable molecules known as free radicals. Free radical damage may lead to cancer. Antioxidants interact with and stabilize free radicals and may prevent some of the damage fre
nutrition intervention trial0.318966
Population Nutrition Intervention0.307215
Minerales Antioxidantes0.329026
mortality during0.312847
skin cancers0.309111
Hercberg S0.31386
complementos antioxidantes alimenticios0.358441
vitamina c0.306663
vitamina a0.307237
Klein EA0.307093
vitamina e0.306864
Virtamo J0.307865
mortality after0.306705
antioxidantes alimenticios0.533634
stopping antioxidant vitamins0.315828
Internal Medicine0.308526
Estados Unidos0.333664
antioxidant vitamins0.315879
PubMed Abstract0.94039
Estudio Demográfico0.30775
follow-up after stopping0.328778
after stopping antioxidant0.315902
skin cancers during0.306731
minerales selenio0.30885
health beneficial effects0.308495
randomized controlled0.317735
International Journal0.310662
health effects0.306579
Kristal AR0.308705
tomar complementos0.660547
Taylor PR0.316391
Ezzedine K0.307269
general population0.307041
supplemental alpha-tocopherol0.309241
Kesse-Guyot E0.307458
tract cancers0.32431
médicos varones0.307704
beta carotene0.315537
elemento mineral selenio0.311109
Cancer Prevention Study0.31922
Cancer Prevention Trial0.339926
complementos alimenticios0.353561
retinol efficacy trial0.343648
SU.VI.MAX Study0.30914
radicales libres0.808852
resultados mixtos0.310828
Cancer Institute0.352968
New England Journal0.317494
Cancer Prevention0.362527
CLICK HERE
3444 National Cancer Institute Html es Exámenes de detección del cáncer de cavidad oral y orofaringe (PDQ®)–Versión para profesionales de salud Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de cavidad oral y orofaringe.
Ramadas K0.326456
Sankaranarayanan R0.337876
accessed march0.331249
Zhang L0.310727
Clinical Preventive Services0.308765
Interim results from0.307724
Sin embargo0.381657
Kerr AR0.312561
American Cancer Society0.427439
Early findings from0.308051
CA Cancer0.323169
cluster randomized controlled0.308479
oral pre-malignant0.326412
oral cancer0.913191
Preventive Services Task0.376173
Instituto Nacional0.317765
Cancer Res0.323621
Human papillomavirus infection0.307515
PDQ Exámenes0.32226
oral cancer screening0.566684
Estados Unidos0.310609
Morton TH Jr0.307383
Morton TH0.311837
Epstein JB0.323025
Database Syst Rev0.307163
visual screening0.315772
screening with0.315479
upper aerodigestive tract0.307566
SEER Cancer Statistics0.324889
Cancer Society guidelines0.325639
Trivandrum Oral Cancer0.343561
carcinoma versus lesiones0.311231
Jacob BJ0.31089
potentially malignant disorders0.308445
Cancer Facts0.324242
Long term effect0.3078
adjacent to clinically0.307949
Oral Oncol0.526329
oral verrucous0.325426
National Cancer Institute0.351683
center grapples with0.307601
Oral Pathol Med0.361585
Screening Study Group0.316915
Am Dent Assoc0.308416
Services Task Force0.375429
Fluorescence visualization detection0.308258
detección versus atención0.319469
Brief Evidence Update0.307856
Poh CF0.312257
CLICK HERE
3565 National Cancer Institute Html en Funding Opportunities Find a wide range of funding announcements to support cancer research and training, organized by topic and by funding mechanism.
population sciences0.493717
promising research areas0.56879
research grants0.500944
AIDS-related cancer0.494918
Cancer Clinical Proteomics0.567175
Cancer Complementary0.503257
mutant RAS-driven cancers0.494379
Cancer Moonshot Blue0.59594
Cancer Nanotechnology Research0.679363
Cancer program0.497422
research community0.507936
cancer patients0.484719
Research projects0.502551
Basic cancer research0.680007
Tissue Sample Collection0.485994
Reduce Cancer Health0.579079
Trans-NIH Research Project0.629695
Cancer Health Disparities0.713271
surveillance cancer research0.666086
basic cancer biology0.601818
Cancer Control0.538781
biostatistical funding opportunities0.51758
Cancer Moonshotâ„  Funding0.624526
Ribbon Panel recommendations0.479686
cancer prevention0.563482
Cancer Treatment0.485294
epidemiological research0.487712
alternative medicine practice0.49686
NCI Alliance0.464504
Provocative Questions Program0.51458
cancer research0.973473
treat cancer0.476905
recent NCI-supported RFAs0.522382
cancer screening procedures0.560144
alternative medicine0.550525
Analysis Technologies Program0.493099
small business0.635559
private sector participation0.462098
health disparities perspective0.521069
RAS Initiative enlists0.522897
Outstanding Investigator Award0.657445
NCI initiative0.486583
Biospecimen Research Branch0.595175
Business Innovation Research0.566067
Translational Research0.497403
Business Technology Transfer0.60463
Small Business Technology0.604737
research communities0.503329
CLICK HERE
16662 National Cancer Institute Html es Qué son el “cerebro en quimio” y el deterioro cognoscitivo después de tratamiento de cáncer Actualización acerca de la investigación de los factores que tienen una función en el
gen apoe0.427379
información meses0.42886
¿estos problemas0.43724
doctor ahles0.800077
peor desempeño0.428323
recientes investigaciones0.427457
gemelos idénticos —una0.452424
larga duración0.464561
cuáles pacientes0.458793
edad afín0.424345
variado deterioro0.472498
Wilmot Cancer Institute0.444334
Funciones Cognoscitivas0.442034
gen bdnf0.427202
doctor tim ahles0.462437
oncológico integral jonsson0.458544
llamada evaluación funcional0.440824
antidepresivo fluoxetina0.426333
sistema nervioso central0.4425
doctora rowland0.544141
actividad neurotransmisor0.425054
doctora patricia ganz0.777152
Oncológico Memorial Sloan0.455699
doctora julia rowland0.500519
quimioterapia 5-FU0.47139
doctora michelle janelsins0.489763
gen comt0.425879
CLICK HERE
17188 National Cancer Institute Html en Fertility Issues in Boys and Men with Cancer Fertility issues are common in boys and men getting cancer treatment. Fertility preservation options include sperm banking, testicular shielding, testicular sperm extraction (TESE), and testicular tissue freezing. Support and clinical trials are listed.
Sexual Health Issues0.508548
cancer treatment0.619036
fertility0.97146
baseline fertility0.628851
family member0.464194
cancer therapy0.481706
health care team0.501109
sperm counts0.505642
fertility problems0.606189
stem cell transplants0.576694
upsetting long-term effects0.50079
Sperm banking0.500128
Testicular tissue freezing0.505046
specific treatment0.473076
fertility clinic0.610475
professionally led support0.49722
sperm-forming cells0.50982
reproductive endocrinologist0.471953
fertility options0.634938
fertility preservation procedures0.624595
Testicular sperm extraction0.553558
radiation therapy0.551741
testicular shielding0.519544
sperm cells0.508932
Reproductive Medicine0.463459
cancer treatments0.62693
blood stem cell0.500463
personal health factors0.507399
fertility preservation options0.794614
testicular tissue cryopreservation0.506676
scatter radiation0.468354
male cancer patients0.603613
fertility preservation0.823931
young male cancer0.600402
fertility risks0.574477
LIVESTRONG Fertility0.586472
rectal cancer0.479468
reproductive age0.463816
sperm0.578609
infertility0.495824
doctor0.471639
fertility specialist0.642942
reproductive medical information0.506006
cancer0.662671
fertility preservation clinic0.634592
fertility preservation discounts0.62021
bone marrow transplants0.501862
child’s doctor0.462088
reproductive organs0.558126
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.